Harvard Medical School-Affiliated Researchers Find One in Five on Paxlovid Experience Covid-19 Rebound
Harvard Medical School-affiliated researchers published research on Nov. 14 showing that one in five patients who used the antiviral drug Paxlovid experienced a rebound case of Covid-19, compared to 2 percent of patients who did not use the drug.
Cornell applied economics professor Prabhu L. Pingali and Nigerian Conservation Foundation director Joseph D. Onoja discussed climate sustainability at the Center for Government and International Studies Tuesday.
Tennessee State Rep. Justin Jones discussed his experiences as an activist, legislator, and minister at a Harvard Divinity School event Thursday.
Experts discussed reproductive justice, domestic violence, and transgender activism at the Harvard Journal of Law and Gender’s annual conference Friday.
More than 600 students representing universities around the country and the world gathered in the Science and Engineering Complex last weekend to participate in HackHarvard, a student-run hackathon.